Page 2 - Cidara Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cidara therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cidara Therapeutic Today - Breaking & Trending Today

Caribou Biosciences (NASDAQ:CRBU) versus Cidara Therapeutics (NASDAQ:CDTX) Head-To-Head Comparison

Caribou Biosciences (NASDAQ:CRBU – Get Rating) and Cidara Therapeutics (NASDAQ:CDTX – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Valuation and Earnings This table compares Caribou Biosciences and […] ....

United States , San Diego , Therapeutics Inc , Caribou Biosciences Inc , Cidara Therapeutics Inc , Abbvie Manufacturing Management Unlimited Company , Caribou Biosciences , Get Rating , Cidara Therapeutics , Cidara Therapeutic , Given Cidara Therapeutic , Caribou Biosciences Daily , Nasdaq Crbu , Stock Comparison , Stock Analysis ,

Critical Comparison: Acumen Pharmaceuticals (NASDAQ:ABOS) and Cidara Therapeutics (NASDAQ:CDTX)

Acumen Pharmaceuticals (NASDAQ:ABOS – Get Rating) and Cidara Therapeutics (NASDAQ:CDTX – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation. Institutional and Insider Ownership 65.6% of Acumen Pharmaceuticals shares […] ....

United States , San Diego , H Shaw Warren , Kevinm Forrest , Acumen Pharmaceuticals Inc , Cidara Therapeutics Inc , Acumen Pharmaceuticals Get Rating , Acumen Pharmaceuticals , Get Rating , Cidara Therapeutics , Cidara Therapeutic , Given Cidara Therapeutic , Nasdaq Abos , Stock Comparison , Stock Analysis ,

Zacks: Analysts Anticipate Cidara Therapeutics, Inc. (NASDAQ:CDTX) Will Post Earnings of -$0.33 Per Share

Equities analysts predict that Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) will report earnings of ($0.33) per share for the current quarter, according to Zacks. Two analysts have issued estimates for Cidara Therapeutics’ earnings. Cidara Therapeutics reported earnings per share of ($0.49) during the same quarter last year, which would suggest a positive year-over-year growth […] ....

San Diego , United States , Thomson Reuter , H Shaw Warren , Kevinm Forrest , Cidara Therapeutics Inc , Zacks Investment Research , Jeppson Wealth Management , Parametric Portfolio Associates , Connor Clark Lunn Investment Management Ltd , Cidara Therapeutics Company Profile Get Rating , Kestra Advisory Services , Dimensional Fund Advisors , Cidara Therapeutics , Get Rating , Cidara Therapeutic , Investment Research , Fund Advisors , Advisory Services , Portfolio Associates , Lunn Investment Management , Wealth Management , Therapeutics Company Profile , Nasdaq Cdtx ,

Analysts Expect Cidara Therapeutics, Inc. (NASDAQ:CDTX) Will Post Earnings of -$0.33 Per Share

Equities analysts expect that Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) will post earnings per share of ($0.33) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Cidara Therapeutics’ earnings. Cidara Therapeutics reported earnings of ($0.49) per share during the same quarter last year, which indicates a positive year over […] ....

San Diego , United States , H Shaw Warren , Kevinm Forrest , Cidara Therapeutics Inc , Zacks Investment Research , Jeppson Wealth Management , Parametric Portfolio Associates , Connor Clark Lunn Investment Management Ltd , Cidara Therapeutics Company Profile Get Rating , Kestra Advisory Services , Dimensional Fund Advisors , Cidara Therapeutics , Get Rating , Cidara Therapeutic , Fund Advisors , Advisory Services , Portfolio Associates , Lunn Investment Management , Wealth Management , Therapeutics Company Profile , Nasdaq Cdtx ,

$3.91 Million in Sales Expected for Cidara Therapeutics, Inc. (NASDAQ:CDTX) This Quarter

$3.91 Million in Sales Expected for Cidara Therapeutics, Inc. (NASDAQ:CDTX) This Quarter
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , H Shaw Warren , Preetam Shah , Kevinm Forrest , Jeffrey Stein , Geode Capital Management , Cidara Therapeutics Inc , Zacks Investment Research , Jeppson Wealth Management , Alethea Capital Management , Topco Ltd , Dimensional Fund Advisors , Cidara Therapeutics , Cidara Therapeutic , Investment Research , Wealth Management , Capital Management , Fund Advisors ,